Thomas Oftedal

• Molecular Biology
• Biochemistry
• Bioinformatics
• Molecular Dynamics
• Programming

List of publications from my research. (Cristin)

Kranjec, C., Oftedal, T. F., Ovchinnikov, K. V., da Silva Duarte, V., Hermansen, S., Kaus-Drobek, M., Sabała, I., Porcellato, D., Carlsen, H., & Kjos, M. (2024). An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy. bioRxiv [PREPRINT].

Oftedal, T.F., Diep, D. B., Kjos, M. (2024). Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach. Probiotics and Antimicrobial Proteins. (IF 2024: 4.9)

Wolden R, Ovchinnikov KV, Venter HJ, Oftedal TF, Diep DB, Cavanagh JP. (2023). The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens. Microbiology Spectrum 11(6): e00869-23 (IF 2023: 3.7)

Oftedal, T.F. (2023) Bacteriocins: from discovery to characterization and applications. Doctoral thesis available at: https://hdl.handle.net/11250/3098644

Oftedal, T. F. (2023). Design of Novel Saposin-like Bacteriocins with Antimicrobial Acitivity using a Hybrid Approach. Poster presentation: IBA Annual Meeting, October 9-10, Clarion Hotel Bjørvika, Oslo, Norway.

Oftedal, T. F. & Diep, D. B. (2023). Flow cytometric detection of vancomycin-resistant Enterococcus faecium in urine using fluorescently labelled enterocin K1. Sci Rep 13, 10930. (IF 2023: 4.6)

Oftedal, T.F. (2023). Detection of E. faecium using the specific interaction of a bacteriocin EntK1 with its receptor. Oral presentation at: Bacteriocin International Conference 2023, June 19-21, Lille, France.

Oftedal, T. F. (2022). Identification of a Novel Two-Peptide Lantibiotic from Vagococcus fluvialis. Poster presentation at: 7th International Symposium on Antimicrobial Peptides - AMP2022, November 7-9, Institut Pasteur, Paris, France.

Kristensen, S. S., Oftedal, T. F., Røhr, Å. K., Eijsink, V. G. H., Mathiesen, G., & Diep, D. B. (2022). The extracellular domain of site-2-metalloprotease RseP is important for sensitivity to bacteriocin EntK1. J. Biol. Chem. In Press. 102593. (IF 2022: 5.5)

Ovchinnikov, K. V., Oftedal, T. F., Reich, S. J., Bar, N. S., Holo, H., Skaugen, M., Riedel, C. U. and Diep, D. B. (2022). Genome-assisted Identification, Purification, and Characterization of Bacteriocins. Bio-protocol 12(14): e4477.  

Oftedal, T.F. (2022). Genome-assisted identification, purification and characterization of a novel bacteriocin. Oral presentation at: International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health, June 27-30, Bratislava, Slovakia.

Rosenbergová, Z., Oftedal, T.F., Ovchinnikov, K.V., Thiyagarajah, T., Rebroš, M., Diep, D.B. (2022). Identification of a Novel Two-Peptide Lantibiotic from Vagococcus fluvialis. Microbiol Spectrum e00954-22. (IF 2022: 9)

Oftedal T.F. (2021). Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS. Poster presented at: IBA Annual Meeting, November 1-2, Oslo, Norway.

Oftedal T.F., Ovchinnikov K.V., Hestad K.A., Goldbeck O., Porcellato D., Narvhus J., Riedel C.U., Kjos M., Diep D.B. (2021). Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS. Microbiology Spectrum 0:e00299-21. (IF 2021: 7.2)

Oftedal T.F. (2019). Co-immunoprecipitation with the Multi-Peptide Bacteriocin GarKS Immunity Protein. Master's thesis submitted to: https://nmbu.brage.unit.no hdl:11250/2606410.